seretide 25 µg/dose - 50 µg/dose druckgasinhalation, suspension
glaxosmithkline pharmaceuticals - fluticasone propionate; salmeterol xinafoate - druckgasinhalation, suspension - 25 µg/dose - 50 µg/dose - fluticasone propionate 50 µg/dose; salmeterol xinafoate 36.3 µg/dose - salmeterol and fluticasone
seretide 25 µg/dose - 125 µg/dose druckgasinhalation, suspension
glaxosmithkline pharmaceuticals - fluticasone propionate; salmeterol xinafoate - druckgasinhalation, suspension - 25 µg/dose - 125 µg/dose - fluticasone propionate 125 µg/dose; salmeterol xinafoate 36.3 µg/dose - salmeterol and fluticasone
seretide 25 µg/dose - 250 µg/dose druckgasinhalation, suspension
glaxosmithkline pharmaceuticals - fluticasone propionate; salmeterol xinafoate - druckgasinhalation, suspension - 25 µg/dose - 250 µg/dose - fluticasone propionate 250 µg/dose; salmeterol xinafoate 36.3 µg/dose - salmeterol and fluticasone
seretide diskus 50 µg/dose - 100 µg/dose einzeldosiertes pulver zur inhalation
glaxosmithkline pharmaceuticals - fluticasone propionate; salmeterol xinafoate - einzeldosiertes pulver zur inhalation - 50 µg/dose - 100 µg/dose - fluticasone propionate 100 µg/dose; salmeterol xinafoate 72.5 µg/dose - salmeterol and fluticasone
seretide diskus 50 µg/dose - 250 µg/dose einzeldosiertes pulver zur inhalation
glaxosmithkline pharmaceuticals - fluticasone propionate; salmeterol xinafoate - einzeldosiertes pulver zur inhalation - 50 µg/dose - 250 µg/dose - fluticasone propionate 250 µg/dose; salmeterol xinafoate 72.5 µg/dose - salmeterol and fluticasone
seretide diskus 50 µg/dose - 500 µg/dose einzeldosiertes pulver zur inhalation
glaxosmithkline pharmaceuticals - fluticasone propionate; salmeterol xinafoate - einzeldosiertes pulver zur inhalation - 50 µg/dose - 500 µg/dose - fluticasone propionate 500 µg/dose; salmeterol xinafoate 72.5 µg/dose - salmeterol and fluticasone
zantac 150 mg brausetablette
glaxosmithkline pharmaceuticals - ranitidine hydrochloride - brausetablette - 150 mg - ranitidine hydrochloride 168 mg - ranitidine
zelitrex 500 mg tablette
glaxosmithkline pharmaceuticals - valaciclovir-hydrochlorid - tablette - 500 mg - valaciclovir-hydrochlorid 556 mg - valaciclovir
tygacil
pfizer europe ma eeig - tigecyclin - bacterial infections; skin diseases, bacterial; soft tissue infections - antibiotika für den systemischen einsatz, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. es sollte erwogen werden, um die offiziellen richtlinien über den angemessenen gebrauch von antibakteriellen wirkstoffen. angemessenen gebrauch von antibakteriellen wirkstoffen.
pifeltro
merck sharp & dohme b.v. - doravirine - hiv-infektionen - antivirale mittel zur systemischen anwendung - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.